Spero Therapeutics
Price & Volume
Stats
See more52W Range | $0.50-$3.22 |
Market Cap | $131.2M |
Shares Short | 615,735 |
Financials
See moreRevenue (12 Mos) | $40.5M |
Revenue Growth (YoY) | -59.6% |
Gross Profit (12 Mos) | -$21.1M |
Diluted EPS | -$0.79 |
News
See moreYahoo Finance • 24 hours ago
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • last month
PIVOT-PO Phase 3 Data Show Tebipenem HBr’s Potential as the First Oral Carbapenem Antibiotic for Patients with Complicated Urinary Tract Infections (cUTIs)
Yahoo Finance • 4 months ago
Spero Therapeutics Announces Second Quarter 2025 Operating Results and Provides a Business Update
About
CEO | Ms. Esther P. Rajavelu |
CFO | Ms. Esther P. Rajavelu |
Address | 675 Massachusetts Avenue, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 32 |
